Missing out on effective care in idiopathic pulmonary fibrosis: Racial inequality in access to anti-fibrotic therapy

被引：0
|
作者：
Pascoe, Amy [1 ]
Smallwood, Natasha [1 ,2 ]
机构：
[1] Monash Univ, Cent Clin Sch, Resp Res, Alfred, Vic, Australia
[2] Alfred Hosp, Dept Resp & Sleep Med, Prahran, Vic, Australia
来源：
RESPIROLOGY | 2023年 / 28卷 / 11期
关键词：
antifibrotic agents; health disparities; health inequities; idiopathic pulmonary fibrosis; interstitial lung disease; mortality; social determinants of health; DISPARITIES; COPD;
D O I：
10.1111/resp.14594
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
See related article
引用
收藏
页码：978 / 979
页数：2
相关论文
共 50 条
  • [41] Anti-fibrotic effect of FGF21 in pulmonary fibrosis
    Ghanem, Mada
    Archer, Gabrielle
    Justet, Aurelien
    Hachem, Mouna
    Boghanim, Tiara
    Vadel, Aurelie
    Pote, Nicolas
    Cazes, Aurelie
    Mordant, Pierre
    Castier, Yves
    Mal, Herve
    Jaillet, Madeleine
    Mailleux, Arnaud
    Crestani, Bruno
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [42] Surfactant protein A as a biomarker of outcomes of anti-fibrotic drug therapy in patients with idiopathic pulmonary fibrosis (vol 20, 27, 2020)
    Yoshikawa, Takumi
    Otsuka, Mitsuo
    Chiba, Hirofumi
    Ikeda, Kimiyuki
    Mori, Yuki
    Umeda, Yasuaki
    Nishikiori, Hirotaka
    Kuronuma, Koji
    Takahashi, Hiroki
    BMC PULMONARY MEDICINE, 2020, 20 (01)
  • [43] Levels of circulating endothelial cells are low in idiopathic pulmonary fibrosis and are further reduced by anti-fibrotic treatments
    Sara De Biasi
    Stefania Cerri
    Elena Bianchini
    Lara Gibellini
    Elisa Persiani
    Gloria Montanari
    Fabrizio Luppi
    Cristiano Matteo Carbonelli
    Luigi Zucchi
    Marialuisa Bocchino
    Alessandro Sanduzzi Zamparelli
    Carlo Vancheri
    Giacomo Sgalla
    Luca Richeldi
    Andrea Cossarizza
    BMC Medicine, 13
  • [44] Levels of circulating endothelial cells are low in idiopathic pulmonary fibrosis and are further reduced by anti-fibrotic treatments
    De Biasi, Sara
    Cerri, Stefania
    Bianchini, Elena
    Gibellini, Lara
    Persiani, Elisa
    Montanari, Gloria
    Luppi, Fabrizio
    Carbonelli, Cristiano Matteo
    Zucchi, Luigi
    Bocchino, Marialuisa
    Zamparelli, Alessandro Sanduzzi
    Vancheri, Carlo
    Sgalla, Giacomo
    Richeldi, Luca
    Cossarizza, Andrea
    BMC MEDICINE, 2015, 13
  • [45] SYSTEMIC ANTI-FIBROTIC EFFECTS OF PIRFENIDONE IN PRECLINICAL STUDIES AND CLINICAL ACTIVITY IN IDIOPATHIC PULMONARY FIBROSIS (IPF)
    Kossen, Karl
    Schaefer, C. J.
    Bradford, W. Z.
    Seiwert, S. D.
    INFLAMMATION RESEARCH, 2012, 61 : S5 - S5
  • [46] WEIGHT LOSS HAS A SIGNIFICANT IMPACT ON ANTI-FIBROTIC DRUG TOLERANCE IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS
    Moon, R. D. C.
    Barker, E.
    Agnew, S.
    Sutcliffe, J.
    Kwok, A.
    Spencer, L. G.
    THORAX, 2017, 72 : A250 - A250
  • [47] Anti-Fibrotic Role Of Inhaled Interferon-γ Detected By Proteomic Studies In Patients With Idiopathic Pulmonary Fibrosis
    Hasaneen, N. A.
    Haley, J.
    Foda, H. D.
    Condos, R.
    Smaldone, G. C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [48] PULMONARY HYPERTENSION IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS ON ANTI-FIBROTIC TREATMENT WITH PIRFENIDONE OR NINTEDANIB: CLINICAL EVALUATION AND PROGNOSTIC IMPACT
    Stornelli, Silvia Romana
    Lacedonia, Donato
    Scioscia, Giulia
    Simone, Filomena
    Lepore, Giorgia
    Sabato, Roberto
    Giganti, Giulio
    Ciliberti, Gianluca
    Barbaro, Maria Pia Foschino
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [49] ELIGIBILITY FOR ANTI-FIBROTIC TREATMENT IN IDIOPATHIC PULMONARY FIBROSIS (IPF) DEPENDS ON THE PREDICTIVE EQUATION USED IN PULMONARY FUNCTION TESTING
    Burgess, Andrew
    Goon, Ken
    Attia, John
    Palazzi, Kerrin
    Brannan, John
    Grainge, Christopher
    RESPIROLOGY, 2017, 22 : 46 - 46
  • [50] The Anti-Fibrotic Role Of Plexin C1 In Pulmonary Fibrosis
    Moore, M. W.
    Mathur, A.
    Gan, Y.
    Herzog, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
12345